Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $132,250 | 6 | 96.8% |
| Food and Beverage | $3,715 | 200 | 2.7% |
| Travel and Lodging | $397.92 | 1 | 0.3% |
| Education | $292.52 | 7 | 0.2% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Roanoke Area Surgical Lasers, LLC | $132,250 | 12 | $0 (2022) |
| Astellas Pharma US Inc | $1,490 | 76 | $0 (2022) |
| NeoTract Inc. | $578.86 | 5 | $0 (2020) |
| PFIZER INC. | $416.07 | 29 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $316.40 | 21 | $0 (2023) |
| United Service Solutions LLC | $177.22 | 1 | $0 (2018) |
| Myovant Sciences Inc. | $156.54 | 10 | $0 (2022) |
| AbbVie Inc. | $146.04 | 8 | $0 (2023) |
| Blue Earth Diagnostics Limited | $137.05 | 6 | $0 (2022) |
| Cook Incorporated | $123.28 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $167.46 | 9 | Sumitomo Pharma America, Inc. ($70.96) |
| 2022 | $5,878 | 37 | Roanoke Area Surgical Lasers, LLC ($5,250) |
| 2021 | $23,723 | 36 | Roanoke Area Surgical Lasers, LLC ($23,000) |
| 2020 | $23,905 | 23 | Roanoke Area Surgical Lasers, LLC ($23,500) |
| 2019 | $30,179 | 48 | Roanoke Area Surgical Lasers, LLC ($29,500) |
| 2018 | $31,087 | 31 | Roanoke Area Surgical Lasers, LLC ($30,000) |
| 2017 | $21,715 | 36 | Roanoke Area Surgical Lasers, LLC ($21,000) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: UROLOGY | ||||||
| 03/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Urology | ||||||
| 03/16/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: HORMONE THERAPY | ||||||
| 03/14/2023 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/21/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: HORMONE THERAPY | ||||||
| 02/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/17/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: HORMONE THERAPY | ||||||
| 01/13/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: UROLOGY | ||||||
| 12/12/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Urology | ||||||
| 12/05/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Urology | ||||||
| 12/01/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2022 | Endo Pharmaceuticals Inc. | EDEX (Drug), XIAFLEX | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: UROLOGY | ||||||
| 11/09/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Oncology | ||||||
| 11/04/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: HORMONE THERAPY | ||||||
| 10/20/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $1.10 | General |
| Category: Kidney Stones | ||||||
| 10/07/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 09/19/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: HORMONE THERAPY | ||||||
| 09/16/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/12/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: UROLOGY | ||||||
| 09/08/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: HORMONE THERAPY | ||||||
| 08/19/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Oncology | ||||||
| 07/28/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 663 | 806 | $123,755 | $30,765 |
| 2022 | 17 | 2,273 | 3,510 | $575,039 | $169,069 |
| 2021 | 21 | 2,582 | 3,888 | $653,379 | $189,216 |
| 2020 | 21 | 2,580 | 3,826 | $610,603 | $169,827 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 72 | $56,304 | $10,506 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 206 | $28,016 | $8,000 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 81 | $17,010 | $5,217 | 30.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 26 | 26 | $10,296 | $3,924 | 38.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 214 | 250 | $4,750 | $981.53 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 107 | 107 | $856.00 | $838.88 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,206 | $515.46 | 16.1% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 14 | 14 | $1,022 | $330.82 | 32.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 11 | $1,320 | $291.83 | 22.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 23 | 25 | $975.00 | $159.03 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 540 | 767 | $104,312 | $45,729 | 43.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 27 | 276 | $215,832 | $37,963 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 349 | $73,290 | $30,370 | 41.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 55 | 101 | $39,996 | $18,851 | 47.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 92 | 92 | $21,068 | $6,547 | 31.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 12 | 15 | $39,210 | $6,409 | 16.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $15,402 | $4,487 | 29.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 661 | 1,055 | $20,045 | $4,159 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $6,050 | $2,786 | 46.1% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 15 | 15 | $6,060 | $2,624 | 43.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 60 | 84 | $6,132 | $1,879 | 30.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 13 | 34 | $6,426 | $1,657 | 25.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 362 | 451 | $3,608 | $1,336 | 37.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 15 | 15 | $4,260 | $1,256 | 29.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 27 | 44 | $5,280 | $1,155 | 21.9% |
About Dr. Robert Whisnant, MD
Dr. Robert Whisnant, MD is a Urology healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609863513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Whisnant, MD has received a total of $136,655 in payments from pharmaceutical and medical device companies, with $167.46 received in 2023. These payments were reported across 220 transactions from 31 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($132,250).
As a Medicare-enrolled provider, Whisnant has provided services to 8,098 Medicare beneficiaries, totaling 12,030 services with total Medicare billing of $558,876. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Roanoke, VA
- Active Since 10/05/2005
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1609863513
Products in Payments
- XTANDI (Drug) $1,044
- UroLift (Device) $578.86
- ORGOVYX (Drug) $210.58
- MYRBETRIQ (Drug) $189.93
- Myrbetriq (Drug) $180.92
- Xtandi (Drug) $171.47
- XIAFLEX (Biological) $164.46
- Axumin (Drug) $137.05
- AVEED (Biological) $118.91
- Cook Medical Extractors (Device) $104.73
- GEMTESA (Drug) $98.36
- TOVIAZ (Drug) $78.32
- FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM (Device) $69.70
- Androgel (Drug) $68.20
- BOTOX (Biological) $59.20
- GENTLECATH (Device) $55.26
- ELIGARD (Drug) $50.88
- Erleada (Drug) $43.66
- Xofigo (Drug) $40.37
- EDEX (Drug) $33.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Roanoke
David Kagey, M.d, M.D
Urology — Payments: $143,426
Yu Zhang, Md, MD
Urology — Payments: $32,265
Dr. Daniel Rukstalis, M.d, M.D
Urology — Payments: $1,439
Mehrad Adibi, Md, MD
Urology — Payments: $324.83
Dr. Joseph Hayes, M.d, M.D
Urology